Stefan K. Nilsson
Lipigon Pharmaceuticals (Sweden)(SE)
Publications by Year
Research Areas
Lipid metabolism and disorders, Diabetes, Cardiovascular Risks, and Lipoproteins, Adipose Tissue and Metabolism, Cancer, Lipids, and Metabolism, Adipokines, Inflammation, and Metabolic Diseases
Most-Cited Works
- → Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis(2013)363 cited
- → FGF21 Lowers Plasma Triglycerides by Accelerating Lipoprotein Catabolism in White and Brown Adipose Tissues(2016)248 cited
- → Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial(2018)208 cited
- → Transforming Growth Factor–β Signaling in T Cells Promotes Stabilization of Atherosclerotic Plaques Through an Interleukin-17–Dependent Pathway(2013)188 cited
- → Lipolysis Triggers a Systemic Insulin Response Essential for Efficient Energy Replenishment of Activated Brown Adipose Tissue in Mice(2018)180 cited
- → Thermogenic adipocytes promote HDL turnover and reverse cholesterol transport(2017)139 cited